Within the blood glucose monitoring systems market, at present, companies are increasingly focusing on the development of advanced next-generation glucose monitoring systems to gain an edge in the current market landscape. Non-invasive glucose monitoring techniques have gained noteworthy popularity over the past couple of decades, and the trend is set to continue to gain momentum during the forecast period. Technological advancements continue to drive innovations in the blood glucose monitoring systems market and improve diagnostic techniques and equipment. Research and development activities continue to explore and discover new non-invasive glucose monitoring techniques.
Over the past few years, research and development activities have put forward infrared spectroscopy– a novel technology that is expected to offer tremendous scope in the blood glucose monitoring systems market. Rapid advancements in technology and improvement in the reliability and calibrating methods of non-invasive devices are some of the factors that are expected to augment the growth of the market for blood glucose monitoring systems in the coming years. The high prevalence of diabetes worldwide is one of the major causes of morbidity and mortality in most regions around the world. Surge in the aging population worldwide, unhealthy dietary patterns, an increase in the number of individuals leading a sedentary lifestyle and obesity are expected to increase the prevalence of diabetes mellitus in the coming years which in turn is expected to propel the demand for advanced blood glucose monitoring systems. At the back of these factors coupled with favorable government policies, the global blood glucose monitoring systems market is expected to reach ~US$ 25 Bn by the end of 2027.
Due to the growing prevalence of diabetes mellitus across the world, the pursuit of efficient blood glucose monitoring systems has gained considerable pace over the past few years– a trend that is likely to continue during the forecast period. Governments of both the developing as well as developed nations of the world are increasingly encouraging research and development activities that aim to minimize health complications caused by blood glucose levels. Non-invasive blood glucose monitoring systems have gained considerable traction in recent years of which, vibrational spectroscopy-based techniques of the skin have emerged as promising candidates.
At present, researchers are also increasingly investigating the potential benefits of deploying devices based on photoplethysmography, wherein wavelengths in near-infrared range are being considered for their exceptional capabilities of offering dependable blood glucose monitoring predictions. Optical glucose sensing is projected to remain one of the most critical types of treatment within the blood glucose monitoring systems market during the forecast period. Steady progress in biosensor technologies and growing emphasis on non-invasive blood glucose monitoring is expected to further accelerate the adoption of optical techniques in the blood glucose monitoring systems market. Advancements in technology have paved the way for a host of blood glucose monitoring systems and techniques, including Raman spectroscopy, fluorescence spectroscopy, absorption spectroscopy, photoacoustic spectroscopy, and ocular spectroscopy, among others.
The future of the blood glucose monitoring systems market is expected to hinge on the strides taken by nanotechnology and significant progress in biomaterials. Companies operating in the current market landscape are expected to develop glucose biosensors that are predominantly based on polymer nanocomposites, carbon nanotubes, and grapheme.
With technology progressing at a rapid pace, several companies are inclined toward the development of advanced blood glucose monitoring systems based on these technologies. Participants in the blood glucose monitoring systems market are expected to collaborate with pharmaceutical companies to launch reliable next-generation glucose monitoring systems. For instance, in January 2019, Eris Lifesciences and India Medtronic Pvt. Ltd announced that the two companies are collaborating to formulate efficient diabetes monitoring programs and initiatives in India. Both companies will leverage expertise from one another to develop advanced blood glucose monitoring systems. Both the companies announced the launch of the smart continuous blood glucose monitoring system, which can be connected with smartphones to gain real-time data, including glucose levels without excessive hardware requirements. Moreover, established brands are also launching new products and expanding their product range to improve their market share. For instance, in January 2018, Abbott announced the launch of the FreeSbtyle Libre System, an advanced continuous glucose monitoring system.
Analysts’ Viewpoint
The global blood glucose monitoring systems market is expected to grow at a steady CAGR of ~5.5% during the forecast period. Some of the leading factors that will contribute to market growth include rapid developments in optical and non-invasive monitoring techniques, high prevalence of diabetes mellitus worldwide, rise in the geriatric population, and policies by government bodies worldwide that encourage the development of reliable, accurate, and efficient blood glucose monitoring systems. Companies should focus on expanding their product portfolio, improve the accuracy of their products, and continue to invest in new technologies to improve their market share in the current market landscape.
Blood Glucose Monitoring Systems Market – Segmentation
|
Product |
Self-monitoring Blood Glucose Systems
Continuous Glucose Monitoring Systems
|
|
Application |
Type 1 Diabetes Type 2 Diabetes Gestational Diabetes |
|
Testing Site |
Fingertip Testing Alternate Site Testing |
|
Patient Care Setting |
Self/Home Care Hospitals Clinics |
|
Region |
Americas Europe Asia Pacific Middle East & Africa |
The global blood glucose monitoring systems market was worth US$ 15.4 Bn and is projected to reach a value of US$ 25 Bn by the end of 2027
Blood glucose monitoring systems market is anticipated to grow at a CAGR of 5.5% during the forecast period
Americas accounted for a major share of the global blood glucose monitoring systems market
Blood Glucose Monitoring Systems Market is driven by rise in prevalence of diabetes, rapid advancements in technology and improvement in the reliability and calibrating methods of non-invasive devices
Key players in the global blood glucose monitoring systems market include Abbott, Medtronic, Hoffmann-La Roche Ltd., B. Braun Melsungen AG, AgaMatrix, Sanofi, SD Biosensor, Inc., LifeScan, Ascensia Diabetes Care, Prodigy Diabetes Care, LLC, Nipro, Dexcom, Inc., Ypsomed AG, Senseonics, and ACON Laboratories, Inc.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Blood Glucose Monitoring Systems Market
4. Market Overview
4.1. Introduction
4.1.1. Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Blood Glucose Monitoring Systems Market Analysis and Forecast, 2017–2027
4.4.1. Market Revenue Projections (US$ Mn)
4.5. Porter’s Five Force Analysis
5. Key Insights
5.1. Price Analysis
5.1.1. Average Price per Meter and Strip
5.1.2. Reimbursement Price by Region
5.2. Disease Prevalence & Incidence Rate Globally with Key Countries
5.3. Key Vendor and Distributor Analysis
5.4. Reimbursement Scenario by Region/Globally
5.5. Supply Chain Analysis, by Country (Market Structure)
5.6. Marketing Strategies and Promotional Activities
6. Global Blood Glucose Monitoring Systems Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product Type, 2017–2027
6.3.1. Self-monitoring Blood Glucose Systems
6.3.1.1. Blood Glucose Meters
6.3.1.2. Testing Strips
6.3.1.3. Lancing Devices
6.3.1.4. Lancets
6.3.2. Continuous Glucose Monitoring Systems
6.3.2.1. Sensors
6.3.2.2. Transmitters
6.3.2.3. Receivers
6.4. Market Attractiveness, by Product Type
7. Global Blood Glucose Monitoring Systems Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Application, 2017–2027
7.3.1. Type 1 Diabetes
7.3.2. Type 2 Diabetes
7.3.3. Gestational Diabetes
7.4. Market Attractiveness, by Application
8. Global Blood Glucose Monitoring Systems Market Analysis and Forecast, by Testing Site
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Testing Site, 2017–2027
8.3.1. Fingertip Testing
8.3.2. Alternate Site Testing
8.4. Market Attractiveness, by Testing Site
9. Global Blood Glucose Monitoring Systems Market Analysis and Forecast, by Patient Care Settings
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast, by Patient Care Settings, 2017–2027
9.3.1. Self/Home Care
9.3.2. Hospitals
9.3.3. Clinics
9.4. Market Attractiveness, by Patient Care Settings
10. Global Blood Glucose Monitoring System Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region
10.2.1. Americas
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Middle East & Africa
10.3. Market Attractiveness, by Country/Region
11. Americas Blood Glucose Monitoring System Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2017–2027
11.2.1. Self-monitoring Blood Glucose Systems
11.2.1.1. . Blood Glucose Meters
11.2.1.2. Testing Strips
11.2.1.3. Lancing Devices
11.2.1.4. Lancets
11.2.2. Continuous Glucose Monitoring Systems
11.2.2.1. Sensors
11.2.2.2. Transmitters
11.2.2.3. Receivers
11.3. Market Value Forecast, by Application, 2017–2027
11.3.1. Type 1 Diabetes
11.3.2. Type 2 Diabetes
11.3.3. Gestational Diabetes
11.4. Market Value Forecast, by Testing Site, 2017–2027
11.4.1. Fingertip Testing
11.4.2. Alternate Site Testing
11.5. Market Value Forecast, by Patient Care Settings, 2017–2027
11.5.1. Self/Home Care
11.5.2. Hospitals
11.5.3. Clinics
11.6. Market Value Forecast, by Country/Sub-region, 2017–2027
11.6.1. U.S.
11.6.2. Canada
11.6.3. Brazil
11.6.4. Mexico
11.6.5. Rest of Americas
11.7. Market Attractiveness Analysis
11.7.1. By Product Type
11.7.2. By Application
11.7.3. By Testing Site
11.7.4. By Patient Care Settings
11.7.5. By Country/Sub-region
11.8. Market Share Analysis by Region for Big and Mid-sized Players
12. Europe Blood Glucose Monitoring System Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2017–2027
12.2.1. Self-monitoring Blood Glucose Systems
12.2.1.1. Blood Glucose Meters
12.2.1.2. Testing Strips
12.2.1.3. Lancing Devices
12.2.1.4. Lancets
12.2.2. Continuous Glucose Monitoring Systems
12.2.2.1. Sensors
12.2.2.2. Transmitters
12.2.2.3. Receivers
12.3. Market Value Forecast, by Application, 2017–2027
12.3.1. Type 1 Diabetes
12.3.2. Type 2 Diabetes
12.3.3. Gestational Diabetes
12.4. Market Value Forecast, by Testing Site, 2017–2027
12.4.1. Fingertip Testing
12.4.2. Alternate Site Testing
12.5. Market Value Forecast, by Patient Care Settings, 2017–2027
12.5.1. Self/Home Care
12.5.2. Hospitals
12.5.3. Clinics
12.6. Market Value Forecast, by Country/Sub-region, 2017–2027
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Poland
12.6.7. Romania
12.6.8. Portugal
12.6.9. Netherlands
12.6.10. Czech
12.6.11. Israel
12.6.12. Austria
12.6.13. Sweden
12.6.14. Denmark
12.6.15. Switzerland
12.6.16. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Product Type
12.7.2. By Application
12.7.3. By Testing Site
12.7.4. By Patient Care Settings
12.7.5. By Country/Sub-region
12.8. Market Share Analysis by Region for Big and Mid-sized Players
13. Asia Pacific Blood Glucose Monitoring System Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2017–2027
13.2.1. Self-monitoring Blood Glucose Systems
13.2.1.1. Blood Glucose Meters
13.2.1.2. Testing Strips
13.2.1.3. Lancing Devices
13.2.1.4. Lancets
13.2.2. Continuous Glucose Monitoring Systems
13.2.2.1. Sensors
13.2.2.2. Transmitters
13.2.2.3. Receivers
13.3. Market Value Forecast, by Application, 2017–2027
13.3.1. Type 1 Diabetes
13.3.2. Type 2 Diabetes
13.3.3. Gestational Diabetes
13.4. Market Value Forecast, by Testing Site, 2017–2027
13.4.1. Fingertip Testing
13.4.2. Alternate Site Testing
13.5. Market Value Forecast, by Patient Care Settings, 2017–2027
13.5.1. Self/Home Care
13.5.2. Hospitals
13.5.3. Clinics
13.6. Market Value Forecast, by Country/Sub-region, 2017–2027
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Indonesia
13.6.5. Philippines
13.6.6. Vietnam
13.6.7. Malaysia
13.6.8. Australia & New Zealand
13.6.9. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Product Type
13.7.2. By Application
13.7.3. By Testing Site
13.7.4. By Patient Care Settings
13.7.5. By Country/Sub-region
13.8. Market Share Analysis by Region for Big and Mid-sized Players
14. Middle East & Africa Blood Glucose Monitoring System Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2017–2027
14.2.1. Self-monitoring Blood Glucose Systems
14.2.1.1. Blood Glucose Meters
14.2.1.2. Testing Strips
14.2.1.3. Lancing Devices
14.2.1.4. Lancets
14.2.2. Continuous Glucose Monitoring Systems
14.2.2.1. Sensors
14.2.2.2. Transmitters
14.2.2.3. Receivers
14.3. Market Value Forecast, by Application, 2017–2027
14.3.1. Type 1 Diabetes
14.3.2. Type 2 Diabetes
14.3.3. Gestational Diabetes
14.4. Market Value Forecast, by Testing Site, 2017–2027
14.4.1. Fingertip Testing
14.4.2. Alternate Site Testing
14.5. Market Value Forecast, by Patient Care Settings, 2017–2027
14.5.1. Self/Home Care
14.5.2. Hospitals
14.5.3. Clinics
14.6. Market Value Forecast, by Country/Sub-region, 2017–2027
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. By Product Type
14.7.2. By Application
14.7.3. By Testing Site
14.7.4. By Patient Care Settings
14.7.5. By Country/Sub-region
14.8. Market Share Analysis by Region for Big and Mid-sized Players
15. Competition Landscape
15.1. Market Player – Competition Matrix (By Tier and Size of companies)
15.2. Market Share Analysis, by Company (2018)
15.3. Company Profiles
15.3.1. Abbott
15.3.1.1. Company Overview
15.3.1.2. Company Financials
15.3.1.3. Growth Strategies
15.3.1.4. SWOT Analysis
15.3.2. Medtronic
15.3.2.1. Company Overview
15.3.2.2. Company Financials
15.3.2.3. Growth Strategies
15.3.2.4. SWOT Analysis
15.3.3. F. Hoffmann-La Roche Ltd
15.3.3.1. Company Overview
15.3.3.2. Company Financials
15.3.3.3. Growth Strategies
15.3.3.4. SWOT Analysis
15.3.4. B.Braun Melsungen AG
15.3.4.1. Company Overview
15.3.4.2. Company Financials
15.3.4.3. Growth Strategies
15.3.4.4. SWOT Analysis
15.3.5. AgaMatrix
15.3.5.1. Company Overview
15.3.5.2. Company Financials
15.3.5.3. Growth Strategies
15.3.5.4. SWOT Analysis
15.3.6. Sanofi-aventis
15.3.6.1. Company Overview
15.3.6.2. Company Financials
15.3.6.3. Growth Strategies
15.3.6.4. SWOT Analysis
15.3.7. SD Biosensor, INC
15.3.7.1. Company Overview
15.3.7.2. Company Financials
15.3.7.3. Growth Strategies
15.3.7.4. SWOT Analysis
15.3.8. LifeScan
15.3.8.1. Company Overview
15.3.8.2. Company Financials
15.3.8.3. Growth Strategies
15.3.8.4. SWOT Analysis
15.3.9. Ascensia Diabetes Care
15.3.9.1. Company Overview
15.3.9.2. Company Financials
15.3.9.3. Growth Strategies
15.3.9.4. SWOT Analysis
15.3.10. Prodigy Diabetes Care, LLC
15.3.10.1. Company Overview
15.3.10.2. Company Financials
15.3.10.3. Growth Strategies
15.3.10.4. SWOT Analysis
15.3.11. Nipro
15.3.11.1. Company Overview
15.3.11.2. Company Financials
15.3.11.3. Growth Strategies
15.3.11.4. SWOT Analysis
15.3.12. Dexcom, Inc.
15.3.12.1. Company Overview
15.3.12.2. Company Financials
15.3.12.3. Growth Strategies
15.3.12.4. SWOT Analysis
15.3.13. Ypsomed AG
15.3.13.1. Company Overview
15.3.13.2. Company Financials
15.3.13.3. Growth Strategies
15.3.13.4. SWOT Analysis
15.3.14. ACON Laboratories, Inc
15.3.14.1. Company Overview
15.3.14.2. Company Financials
15.3.14.3. Growth Strategies
15.3.14.4. SWOT Analysis
15.3.15. Senseonics
15.3.15.1. Company Overview
15.3.15.2. Company Financials
15.3.15.3. Growth Strategies
15.3.15.4. SWOT Analysis
15.3.16. Other Prominent Players
List of Table
Table 01 Diabetes Prevalence in Key Countries
Table 02 Diabetes Prevalence in Key Countries
Table 03 Diabetes Prevalence in Key Countries
Table 04 Global Blood Glucose Monitoring Systems Market Value (US$ Mn) Forecast, by Product Type, 2017–2027
Table 05 Global Blood Glucose Monitoring Systems Market Value (US$ Mn) Forecast, by Self-monitoring Blood Glucose Systems, 2017–2027
Table 06 Global Blood Glucose Monitoring Systems Market Value (US$ Mn) Forecast, by Continuous Glucose Monitoring Systems, 2017–2027
Table 07 Global Blood Glucose Monitoring Systems Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 08 Global Blood Glucose Monitoring Systems Market Value (US$ Mn) Forecast, by Testing Site, 2017-2027
Table 09 Global Blood Glucose Monitoring Systems Market Value (US$ Mn) Forecast, by Patient Care Setting, 2017–2027
Table 10 Global Blood Glucose Monitoring Systems Market Value (US$ Mn) Forecast, by Region, 2017–2027
Table 11 Americas Blood Glucose Monitoring System Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 12 Americas Blood Glucose Monitoring System Market Value (US$ Mn) Forecast, by Product Type, 2017–2027
Table 13 Americas Blood Glucose Monitoring System Market Value (US$ Mn) Forecast, by Self-monitoring Blood Glucose Systems, 2017–2027
Table 14 Americas Blood Glucose Monitoring System Market Value (US$ Mn) Forecast, by Continuous Glucose Monitoring Systems, 2017–2027
Table 15 Americas Blood Glucose Monitoring System Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 16 Americas Blood Glucose Monitoring System Market Value (US$ Mn) Forecast, by Testing Site, 2017–2027
Table 17 Americas Blood Glucose Monitoring System Market Value (US$ Mn) Forecast, by Patient Care Setting, 2017–2027
Table 18 Europe Blood Glucose Monitoring System Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 19 Europe Blood Glucose Monitoring System Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 20 Europe Blood Glucose Monitoring System Market Value (US$ Mn) Forecast, by Product Type, 2017–2027
Table 21 Europe Blood Glucose Monitoring System Market Value (US$ Mn) Forecast, by Self-monitoring Blood Glucose Systems, 2017–2027
Table 22 Europe Blood Glucose Monitoring System Market Value (US$ Mn) Forecast, by Continuous Glucose Monitoring Systems, 2017–2027
Table 23 Europe Blood Glucose Monitoring System Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 24 Europe Blood Glucose Monitoring System Market Value (US$ Mn) Forecast, by Testing Site, 2017-2027
Table 25 Europe Blood Glucose Monitoring System Market Value (US$ Mn) Forecast, by Patient Care Setting, 2017–2027
Table 26 Asia Pacific Blood Glucose Monitoring System Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 27 Asia Pacific Blood Glucose Monitoring System Market Value (US$ Mn) Forecast, by Product Type, 2017–2027
Table 28 Asia Pacific Blood Glucose Monitoring System Market Value (US$ Mn) Forecast, by Self-monitoring Blood Glucose Systems, 2017–2027
Table 29 Asia Pacific Blood Glucose Monitoring System Market Value (US$ Mn) Forecast, Continuous Glucose Monitoring Systems, 2017–2027
Table 30 Asia Pacific Blood Glucose Monitoring System Market Value (US$ Mn) Forecast, by Application, 2017-2027
Table 31 Asia Pacific Blood Glucose Monitoring System Market Value (US$ Mn) Forecast, by Testing Site, 2017-2027
Table 32 Asia Pacific Blood Glucose Monitoring System Market Value (US$ Mn) Forecast, by Patient Care Setting, 2017–2027
Table 33 Middle East & Africa Blood Glucose Monitoring System Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 34 Middle East & Africa Blood Glucose Monitoring System Market Value (US$ Mn) Forecast, by Product Type, 2017–2027
Table 35 Middle East & Africa Blood Glucose Monitoring System Market Value (US$ Mn) Forecast, by Product, Self-monitoring Blood Glucose Systems 2017–2027
Table 36 Middle East & Africa Blood Glucose Monitoring System Market Value (US$ Mn) Forecast, by Product, Continuous Glucose Monitoring Systems 2017–2027
Table 37 Middle East & Africa Blood Glucose Monitoring System Market Value (US$ Mn) Forecast, by Application, 2018-2028
Table 38 Middle East & Africa Blood Glucose Monitoring System Market Value (US$ Mn) Forecast, by Testing Site, 2018-2028
Table 39 Middle East & Africa Blood Glucose Monitoring System Market Value (US$ Mn) Forecast, by Patient Care Setting, 2017–2027
List of Figures
Figure 01 Global Blood Glucose Monitoring Systems Market Value (US$ Mn) and Distribution (%), by Region, 2018 and 2027
Figure 02 Global Blood Glucose Monitoring Systems Market Value (US$ Mn) Forecast, 2017–2027
Figure 03 Global Blood Glucose Monitoring Systems Market Value Share Analysis, by Product Type, 2019 and 2027
Figure 04 Global Blood Glucose Monitoring Systems Market Attractiveness Analysis, by Product Type, 2018–2027
Figure 05 Global Blood Glucose Monitoring Systems Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Self-monitoring Blood Glucose Systems, 2017–2027
Figure 06 Global Blood Glucose Monitoring Systems Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Continuous Glucose Monitoring Systems, 2017–2027
Figure 07 Global Blood Glucose Monitoring Systems Market Value Share Analysis, by Application, 2019 and 2027
Figure 08 Global Blood Glucose Monitoring Systems Market Attractiveness Analysis, by Application, 2019–2027
Figure 09 Global Blood Glucose Monitoring Systems Market Revenue (US$ Mn) and Y-o-Y Growth (%), Type 1 Diabetes, 2017–2027
Figure 10 Global Blood Glucose Monitoring Systems Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Type 2 Diabetes, 2017–2027
Figure 11 Global Blood Glucose Monitoring Systems Market Revenue (US$ Mn) and Y-o-Y Growth (%), Gestational Diabetes, 2017–2027
Figure 12 Global Blood Glucose Monitoring Systems Market Value Share Analysis, by Testing Site, 2019 and 2027
Figure 13 Global Blood Glucose Monitoring Systems Market Attractiveness Analysis, by Testing Site, 2019–2027
Figure 14 Global Blood Glucose Monitoring Systems Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Fingertip Testing, 2017-2027
Figure 15 Global Blood Glucose Monitoring Systems Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Alternate Site Testing, 2017-2027
Figure 16 Global Blood Glucose Monitoring Systems Market Value Share Analysis, by Patient Care Setting, 2019 and 2027
Figure 17 Global Blood Glucose Monitoring Systems Market Attractiveness Analysis, by Patient Care Setting, 2019–2027
Figure 18 Global Blood Glucose Monitoring Systems Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Self/Home Care, 2017–2027
Figure 19 Global Specialty Clinics Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospitals, 2017–2027
Figure 20 Global Blood Glucose Monitoring Systems Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Clinics, 2017–2027
Figure 21 Global Blood Glucose Monitoring Systems Market Attractiveness, by Region, 2019–2027
Figure 22 Global Blood Glucose Monitoring Systems Market Value Share, by Region, 2019 and 2027
Figure 23 Americas Blood Glucose Monitoring System Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027
Figure 24 Americas Blood Glucose Monitoring System Market Attractiveness, by Country/Sub-region, 2019–2027
Figure 25 Americas Blood Glucose Monitoring System Market Value Share, by Country, 2018 and 2027
Figure 26 Americas Blood Glucose Monitoring System Market Value Share Analysis, by Product Type, 2018 and 2027
Figure 27 Blood Glucose Monitoring System Market Attractiveness Analysis, by Product Type, 2019–2027
Figure 28 Americas Blood Glucose Monitoring System Market Value Share Analysis, by Application, 2018 and 2027
Figure 29 Americas Blood Glucose Monitoring System Market Attractiveness Analysis, by Application, 2019–2027
Figure 30 Americas Blood Glucose Monitoring System Market Value Share Analysis, by Testing Site, 2018 and 2027
Figure 31 Americas Blood Glucose Monitoring System Market Attractiveness Analysis, by Testing Site, 2019–2027
Figure 32 Americas Blood Glucose Monitoring System Market Value Share Analysis, by Patient Care Setting, 2018 and 2027
Figure 33 Americas Blood Glucose Monitoring System Market Attractiveness Analysis, by Patient Care Setting, 2019–2027
Figure 34 Americas Self-monitoring Blood Glucose Systems Market Share, by Company, 2018
Figure 35 Americas Self-monitoring Blood Glucose Systems Market Share, by Mid-sized Company, 2018
Figure 36 Americas Continuous Glucose Monitoring Systems Market Share, by Company, 2018
Figure 37 Americas Continuous Glucose Monitoring Systems Market Share, by Mid-sized Company, 2018
Figure 38 Europe Blood Glucose Monitoring System Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027
Figure 39 Europe Blood Glucose Monitoring System Market Attractiveness, by Country/Sub-Region, 2019–2027
Figure 40 Europe Blood Glucose Monitoring System Market Value Share, by Country/Sub-Region, 2018 and 2027
Figure 41 Europe Blood Glucose Monitoring System Market Value Share Analysis, by Product, 2018 and 2027
Figure 42 Europe Blood Glucose Monitoring System Market Attractiveness Analysis, by Product, 2019–2027
Figure 43 Europe Blood Glucose Monitoring System Market Value Share Analysis, by Application, 2018 and 2027
Figure 44 Europe Blood Glucose Monitoring System Market Attractiveness Analysis, by Application, 2019–2027
Figure 45 Europe Blood Glucose Monitoring System Market Value Share Analysis, by Testing Site, 2018 and 2027
Figure 46 Europe Blood Glucose Monitoring System Market Attractiveness Analysis, by Testing Site, 2019–2027
Figure 47 Europe Blood Glucose Monitoring System Market Value Share Analysis, by Patient Care Setting, 2018 and 2027
Figure 48 Europe Blood Glucose Monitoring System Market Attractiveness Analysis, by Patient Care Setting, 2019–2027
Figure 49 Europe & Middle East Africa Self-monitoring Blood Glucose Systems Market Share, by Company, 2018
Figure 50 Europe & Middle East Africa Self-monitoring Blood Glucose Systems Market Share, by Mid-sized Company, 2018
Figure 51 Europe & Middle East Africa Continuous Glucose Monitoring Systems Market Share, by Company, 2018
Figure 52 Europe & Middle East Africa Continuous Glucose Monitoring Systems Market Share, by Mid-sized Company, 2018
Figure 53 Asia Pacific Blood Glucose Monitoring System Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027
Figure 54 Asia Pacific Blood Glucose Monitoring System Market Attractiveness, by Country/Sub-Region, 2019–2027
Figure 55 Asia Pacific Blood Glucose Monitoring System Market Value Share, by Country/Sub-Region, 2019–2027
Figure 56 Asia Pacific Blood Glucose Monitoring System Market Value Share Analysis, by Product, 2018 and 2027
Figure 57 Asia Pacific Blood Glucose Monitoring System Market Attractiveness Analysis, by Product, 2019–2027
Figure 58 Asia Pacific Blood Glucose Monitoring System Market Value Share Analysis, by Application, 2018 and 2027
Figure 59 Asia Pacific Blood Glucose Monitoring System Market Attractiveness Analysis, by Application, 2019–2027
Figure 60 Asia Pacific Blood Glucose Monitoring System Market Value Share Analysis, by Testing Site, 2018 and 2027
Figure 61 Asia Pacific Blood Glucose Monitoring System Market Attractiveness Analysis, by Testing Site, 2019–2027
Figure 62 Asia Pacific Blood Glucose Monitoring System Market Value Share Analysis, by Patient Care Setting, 2018 and 2027
Figure 63 Asia Pacific Blood Glucose Monitoring System Market Attractiveness Analysis, by Patient Care Setting, 2019–2027
Figure 64 Asia Pacific Self-monitoring Blood Glucose Systems Market Share, by Company, 2018
Figure 65 Asia Pacific Self-monitoring Blood Glucose Systems Market Share, by Mid-sized Company, 2018
Figure 66 Asia Pacific Continuous Glucose Monitoring Systems Market Share, by Company, 2018
Figure 67 Asia Pacific Continuous Glucose Monitoring Systems Market Share, by Mid-sized Company, 2018
Figure 68 Middle East & Africa Blood Glucose Monitoring System Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%),
Figure 69 Middle East & Africa Blood Glucose Monitoring System Market Attractiveness, by Country/Sub-region, 2019–2027
Figure 70 Middle East & Africa Blood Glucose Monitoring System Market Value Share, by Country/Sub-region, 2018 and 2027
Figure 71 Middle East & Africa Blood Glucose Monitoring System Market Value Share Analysis, by Product, 2018 and 2027
Figure 72 Middle East & Africa Blood Glucose Monitoring System Market Attractiveness Analysis, by Product, 2019–2027
Figure 73 Middle East & Africa Blood Glucose Monitoring System Market Value Share Analysis, by Application, 2018 and 2027
Figure 74 Middle East & Africa Blood Glucose Monitoring System Market Attractiveness Analysis, by Application, 2019–2027
Figure 75 Middle East & Africa Blood Glucose Monitoring System Market Value Share Analysis, by Testing Site, 2018 and 2027
Figure 76 Middle East & Africa Blood Glucose Monitoring System Market Attractiveness Analysis, by Testing Site, 2019–2027
Figure 77 Middle East & Africa Blood Glucose Monitoring System Market Value Share Analysis, by Patient Care Setting, 2018 and 2027
Figure 78 Middle East & Africa Blood Glucose Monitoring System Market Attractiveness Analysis, by Patient Care Setting, 2019–2027
Figure 79 Global Self-monitoring Blood Glucose Systems Market Share, by Company, 2018
Figure 80 Global Continuous Glucose Monitoring Systems Market Share, by Company, 2018
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Blood Glucose Monitoring Systems Market
